August 31, 2023

Biomarkers for cognitive dysfunction after COVID-19 hospitalisation (PHOSP study)

Researchers have studied the blood of patients who were hospitalised with COVID-19, reporting two biomarkers measured during admission which are able to predict cognitive issues at 6 and 12 months later. Published in Nature Medicine, as part of the PHOSP study (Post-hospitalisation COVID-19), journalists dialled in to hear from the authors about their research and what it can tell us about the mechanisms of cognitive issues after COVID-19.

Speakers included:

Dr Max Taquet, NIHR Academic Clinical Fellow in Psychiatry, University of Oxford

Prof Paul Harrison, Professor of Psychiatry, University of Oxford

Prof John Geddes, Head of Department of Psychiatry at the University of Oxford and Director of the Oxford Health Biomedical Research Centre

Prof Chris Brightling, Professor of Respiratory Medicine, University of Leicester

This Briefing was accompanied by an SMC Roundup of Comments.